top of page

OUR JOURNEY

_edited.jpg

FROM VISION TO VISUALIZATION

OUR STORY

Power. Precision. Innovation. Ingenuity.

Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Pyxa suite of products was developed to extend their progress by empowering others to innovate alongside them. With Pyxa, any researcher or clinician can create fully annotated cellular maps for clearer understanding of disease progression and response to therapy.

About1.png

Our journey so far

2018

STARmap IS DEVELOPED

Stellaromics founders patent a novel technology for identifying high resolution 3D transcription patterns in native biological tissue using hydrogel tissue chemistry.

2022

STELLAROMICS IS LAUNCHED

Scientists, operators and investors come together to extend the value of STARmap technology, developing a product suite to empower biomedical innovation worldwide.

2023

PRE-SALE FOR PYXA IN SITU ANALYZER

Now, all types of researchers can pre-order the first Stellaromics product, Pyxa In Situ Analyzer. Sign up for updates regarding the Pyxa launch and early access.

Image by Greg Rakozy
bottom of page